Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit
Journal of Analytical Toxicology · 2026
DOI: 10.1093/jat/bkag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2026. Verfasst von Shaza Deeb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Omega Laboratories, Inc., Mogadore, OH 44260, United States. Hauptthemen laut MEDLINE: Dronabinol, Substance Abuse Detection, Cannabinoids, Cannabidiol. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Omega Laboratories, Mogadore, OH, USA and Cannabix Technologies Inc., Burnaby, BC, Canada.
Abstract (Originalsprache)
A simple, accurate, and cost-effective liquid chromatography-tandem mass spectrometric (LC-MS/MS) method has been developed and validated for the simultaneous quantification of Δ9-tetrahydrocannabinol (Δ9-THC), Δ8-tetrahydrocannabinol (Δ8-THC), cannabidiol (CBD), and cannabinol (CBN) in breath aerosols collected using the Cannabix Technologies’ Breath Collection Unit (BCU). The method is suitable for use in workplace drug testing and in the investigation of driving under the influence of drugs (DUID) cases. The method was validated according to ANSI/ASB Standard 036, First Edition 2019 guidelines. A lower limit of quantification (LLOQ) of 2.5 pg/L was achieved. Calibration curves were linear (R2 > 0.995) and quality control (QC) accuracy between 91.3% and 100.5% with precision (%CV) less than 17.7%. No major matrix effects or drug interferences were observed. Samples were stable at room temperature and refrigerated at 2-8 °C up to 7 days. Breath samples were collected using the BCU from volunteer regular cannabis users before cannabis consumption and at multiple timepoints after smoking cannabis up to 90 minutes. The results verified the methods ability to capture and quantitate the cannabinoids in breath. The data indicated similar concentration versus time trends for THC metabolism assessed from breath to that previously reported from blood. Breath is an alternative, non-invasive sample matrix that holds promise for identifying recent cannabis use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Omega Laboratories, Inc., Mogadore, OH 44260, United States.
- Cannabix Technologies Inc., Burnaby, BC V5A 4R4, Canada.
ORCID-Profile: Shaza Deeb
Förderung
- Omega Laboratories, Mogadore, OH, USA and Cannabix Technologies Inc., Burnaby, BC, Canada
Zitieren
APA
Deeb, S., Fabian, Z. E., Määttä, M., Fraccarolli, P., & Engelhart, D. A. (2026). Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkag016
Vancouver
Deeb S, Fabian ZE, Määttä M, Fraccarolli P, Engelhart DA. Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit. Journal of Analytical Toxicology. 2026. doi:10.1093/jat/bkag016
BibTeX
@article{Deeb2026,
author = {Deeb, Shaza and Fabian, Zaire E and Määttä, Mikko and Fraccarolli, Pedro and Engelhart, David A},
title = {Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit},
journal = {Journal of Analytical Toxicology},
year = {2026},
doi = {10.1093/jat/bkag016}
}
EUVIMED